Sanctuary Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Sanctuary Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$806K	Sell	2,829 -153	-5%	-$45.1K	﹤0.01%	1613
2026 Q1	$886K	Buy	2,982 +99	+3%	+$32K	﹤0.01%	1409
2025 Q4	$876K	Sell	2,883 -83	-3%	-$27.2K	﹤0.01%	1394
2025 Q3	$1.01M	Sell	2,966 -797	-21%	-$242K	0.01%	1275
2025 Q2	$911K	Buy	3,763 +858	+30%	+$210K	0.01%	1272
2025 Q1	$791K	Sell	2,905 -1,610	-36%	-$376K	0.01%	1247
2024 Q4	$1.02M	Buy	4,515 +31	+0.7%	+$6.33K	0.01%	1244
2024 Q3	$854K	Sell	4,484 -2,277	-34%	-$410K	0.01%	1348
2024 Q2	$1.04M	Buy	+6,761	New	+$1.04M	0.01%	1172

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sanctuary Advisors's ONC Position: Q2 2026 in Review

Sanctuary Advisors reduced its BeOne Medicines Ltd (ONC) stake by 5.1% in Q2 2026, selling an estimated $45.1K and leaving 2,829 shares worth $806K. The position accounts for ﹤0.01% of the portfolio, ranked #1613.

Sanctuary Advisors first reported a position in ONC in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.04M in Q2 2024. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Sanctuary Advisors held 2,829 shares of BeOne Medicines Ltd worth $806K as of Q2 2026.
Sanctuary Advisors sold 153 BeOne Medicines Ltd shares in Q2 2026, an estimated $45.1K.
BeOne Medicines Ltd made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1613 holding.
Sanctuary Advisors first reported a position in BeOne Medicines Ltd in Q2 2024 and has held it in 9 quarters since.
Sanctuary Advisors's BeOne Medicines Ltd position peaked at $1.04M in Q2 2024.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.